Industry Voices: Time to Take Fecal Transplantation Seriously

Alok Saboo By Bernat Olle, PureTech Ventures The NEJM‘s recent publication of the first randomized, controlled trial of fecal transplantation (FT) is a big deal for research ...

The Top 15 Biotech VC firms

Alok Saboo Ask any biotech exec in the business of drug and device development about the funding environment these days, and you’ll most likely hear the word “tough” ...

Top 10 pharma companies by employees

Eric Palmer Being the largest company by any number of measures–revenues, earnings, those kinds of yardsticks–is a good thing. Being the largest by number of employees ...

Vivus revs up new Qsymia sales plan after FDA removes a roadblock

Tracy Staton Vivus’ weight-loss drug Qsymia–courtesy of Vivus. The FDA has agreed to take down one of the big hurdles hampering U.S. sales of Vivus’ newly ...

Merck kept mum on Fosamax’s fracture risks, trial lawyer says

Tracy Staton Image courtesy of NIH Did Merck know about increased fracture risk in Fosamax patients years before the osteoporosis treatment hit the market? A plaintiff’s ...

Sanofi downsizing in France drags on

Eric Palmer CEO Chris Viehbacher Sanofi CEO Chris Viehbacher has been openly critical of his research operation in Toulouse, France. He said the researchers are costing too ...

Eli Lilly to lay off hundreds in sales as Cymbalta nears edge of patent cliff

Here is a business reality that hundreds of Eli Lilly ($ LLY) sales employees are going to have to align themselves with quite soon: They are about to lose their jobs. With its best-selling ...

Irish app certified by CE as a medical device

An app developed specifically for oncologists by an Irish software company has just received CE certification – the third app in the world to do so. ONCOassist is a new smartphone ...

Pfizer gets Celebrex patent extension, sues generic companies

(Reuters) – U.S. regulators granted Pfizer Inc a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December ...

Roche wins FDA nod for hep C diagnostic

By Damian Garde Roche ($RHHBY) has secured the FDA’s blessing for a new viral load hepatitis C test, designed to gauge a patient’s response to treatment by identifying ...

Targacept, AstraZeneca amend terms of collaboration

By Matt Evans Targacept Inc. and AstraZeneca, a pharmaceutical industry partner that has licensed and funded some of Targacept’s drug discovery efforts, have amended their ...

Dako wins companion Dx approval for Roche’s Kadcyla

FDA OKs test paired with blockbuster-hopeful cancer drug By Damian Garde Dako has been on a tear with big-name companion diagnostics partnerships, and its latest one might end up ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS